Skip to main content

Advertisement

SpringerLink
Log in

Economic Outcomes for the Treatment of Allergic Rhinitis

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

The purpose of this article is to review the literature related to economic outcomes associated with treating allergic rhinitis. A literature review was conducted using ‘Medline’ and the in-house database of the publishers of this journal for articles published between January 1991 and January 1996. Only 3 cost-outcome analyses that compared alternative treatments for allergic rhinitis were found. Given the limited number of full economic evaluations, much of this article focuses on issues related to direct and indirect costs and outcome measures that should be considered when performing an economic evaluation of allergic rhinitis. We conclude that more comprehensive analyses using a wide array of costs and outcomes are needed. At present, it is not possible to draw general conclusions regarding the economic value of alternative treatments for allergic rhinitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Young P. Asthma and allergies: an optimistic future. National Institutes of Health (NIH) publication no. 80-388. Bethesda (MD): US Department of Health and Human Services, NIH, 1980 Mar

    Google Scholar 

  2. Report of the NIAID task force on immunology and allergy. National Institutes of Health (NIH) publication no. 91-2414. Bethesda (MD): US Department of Health and Human Services, NIH, 1990 Sep

  3. Naclerio RM. Allergic rhinitis. N Engl J Med 1991; 325(12). 860–9

    Article  PubMed  CAS  Google Scholar 

  4. Rimpela AH, Savonius B, Rimpela MK, et al. Asthma and allergic rhinitis among Finnish adolescents in 1977–1991. Scand J Soc Med 1995; 23: 60–5

    PubMed  CAS  Google Scholar 

  5. Magnussen H, Jorres R, Nowak D. Effect of air pollution on the prevalence of asthma and allergy: lessons from the German reunification. Thorax 1993; 48: 879–81

    Article  PubMed  CAS  Google Scholar 

  6. Sibbald B. Epidemiology of allergic rhinitis. Monogr Allergy 1993; 31: 61–79

    PubMed  CAS  Google Scholar 

  7. Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. BMJ 1987 Jan 31; 294: 279–83

    Article  PubMed  CAS  Google Scholar 

  8. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy 1994 Jul; 73: 35–9

    PubMed  CAS  Google Scholar 

  9. Wilson JD, Braunwald E, Isselbacher KJ, et al., editors. Harrison’s principles of internal medicine. New York: McGraw-Hill 1991

    Google Scholar 

  10. Wood S. Allergic rhinitis and hayfever. Practitioner 1992 Apr;236: 440–7

    PubMed  CAS  Google Scholar 

  11. May JR. Allergic rhinitis. In: Dipiro JT, Talbert RL, Hayes PE, et al., editors. Pharmacotherapy: a pathophysiologic approach. New York: Elsevier 1989: 945–53

    Google Scholar 

  12. Definition and classification of rhinitis. Allergy 1994; 19 Suppl. 19: 5–34

  13. Drummond MF, Stoddart GL, Torrance GW. Methods for the evaluation of health care programmes. Oxford: Oxford University Press, 1987

    Google Scholar 

  14. Tarnasky PR, Van Arsdal Jr PP. Antihistamine therapy in allergic rhinitis. J Fam Pract 1990; 30(1): 71–80

    PubMed  CAS  Google Scholar 

  15. Assessing and treating rhinitis: a practical guide for Canadian physicians. Proceedings of the Canadian Rhinitis Symposium; 1994 Jan 14–15: Toronto. Can Med Assoc J 1994 Aug 15; 151 (4 Suppl.): 1–27

  16. Dockhorn RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy 1987 Jun; 58: 407–11

    PubMed  CAS  Google Scholar 

  17. Aaronson DW. Comparative efficacy of H1 antihistamines. Ann Allergy 1991 Nov; 67: 541–7

    PubMed  CAS  Google Scholar 

  18. Prevost M, Turenne Y, Moote W, et al. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis. Clin Ther 1994; 16(1): 50–6

    PubMed  CAS  Google Scholar 

  19. Ziering RW, Klein GL. Allergic rhinitis. Postgrad Med 1991 Jan; 91 (1): 225–32

    Google Scholar 

  20. Juniper EF, Guyatt GH. Development of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21: 77–83

    Article  PubMed  CAS  Google Scholar 

  21. Juniper EF, Willms DG, Guyatt GH, et al. Aqueous beclomethasone dipropionate nasal spray in the treatment of seasonal (ragweed) rhinitis. Can Med Assoc J 1992 Sep 15; 147(6): 887–92

    CAS  Google Scholar 

  22. Juniper EF, Guyatt GH, Archer B, et al. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of ‘as needed’ use. J Allergy Clin Immunol 1993; 92: 66–72

    Article  PubMed  CAS  Google Scholar 

  23. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994; 93: 413–23

    Article  PubMed  CAS  Google Scholar 

  24. Mackowiak JI. Fluticasone propionate aqueous nasal spray improves rhinitis quality of life and reduces lost labor costs [abstract]. Ann Allergy 1994; 72: 99A

    Google Scholar 

  25. Leickly F, Higgins D, Ownby D. A comparative cost-effectiveness study of two treatment modalities for ragweed hay fever [abstract]. J Allergy Clin Immunol 1987; 79: 189A

    Google Scholar 

  26. Berka C, Chin W. Fluticasone propionate intranasal steroid: cost-effectiveness vs antihistamines [abstract]. J Allergy Clin Immunol 1994 Jan; 93 (1 Pt 2): 165

    Google Scholar 

  27. Kozma CM, Schulz RM, Sclar DA. A comparison of costs and efficacy of fluticasone propionate aqueous nasal spray (FP) and terfenadine tablets [abstract]. Ann Allergy 1994 Jan; 72: 58

    Google Scholar 

  28. Medi-Span Inc. Medi-Span Prescription Pricing Guide. Indianapolis: Medi-Span Inc., 1993 Feb

    Google Scholar 

  29. Bootman JL, Townsend RJ, McGhan WE. Principles of pharmacoeconomics. Cincinnati: Harvey Whitney Books Company, 1991

    Google Scholar 

  30. McLemore T. National Ambulatory Medical Care Survey: 1985 summary. Hyattsville (MD): National Center for Health Statistics, 1987 Jun

    Google Scholar 

  31. International Classification of Diseases Clinical Modification. 9th rev. ed. Washington, DC: US Department of Health and Human Services, 1992

  32. Kaliner M, Lemanske R. Rhinitis and asthma. JAMA 1992 Nov 25; 268(20): 2807–29

    Article  PubMed  CAS  Google Scholar 

  33. Weeke ER. Epidemiology of hay fever and perennial allergic rhinitis. Monogr Allergy 1987; 21: 1–20

    PubMed  CAS  Google Scholar 

  34. US Department of Health and Human Services. Asthma and allergy statistics. National Institute for Allergy and Infectious Diseases Statistics. Washington, DC: US Department of Health and Human Services, National Institutes of Health, 1995 May

    Google Scholar 

  35. US Department of Health and Human Services. National Center for Health Statistics Telephone Statistics (301-436-8500). Washington, DC: US Department of Health and Human Services, National Institutes of Health, 1995

    Google Scholar 

  36. Varney V. Hayfever in the United Kingdom. Clin Exp Allergy 1991; 21: 757–62

    Article  PubMed  CAS  Google Scholar 

  37. Vervloet D, van der Brempt X, Charpin D, et al. Immunotherapy in allergic respiratory diseases. Lung 1990; 168 Suppl.: 1013–24

    Article  PubMed  Google Scholar 

  38. Varney VA, Gaga M, Frew AJ, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991 Feb 2; 302: 265–9

    Article  PubMed  CAS  Google Scholar 

  39. Vuurman E, van Veggel L, Uiterwijk M, et al. Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy 1993 Aug 17; 71: 121–6

    PubMed  CAS  Google Scholar 

  40. Berman BA. Allergic rhinitis: mechanisms and management. J Allergy Clin Immunol 1988; 81: 980–4

    Article  PubMed  CAS  Google Scholar 

  41. Richards S, Thornhill D, Roberts H, et al. How many people think they have hay fever and what they do about it. Br J Gen Pract 1992 Jul; 42: 284–6

    PubMed  CAS  Google Scholar 

  42. Bindslev-Jenson C. Antihistamines. In: Hvidberg EF, editor. Meyler’s side effects of drugs. Amsterdam: Elsevier, 1992: 366–72

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of South Carolina, Columbia, South Carolina, 29208, USA

    Chris M. Kozma (Assistant Professor), M. Kay Sadik & Marc L. Watrous

Authors
  1. Chris M. Kozma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Kay Sadik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc L. Watrous
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chris M. Kozma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kozma, C.M., Kay Sadik, M. & Watrous, M.L. Economic Outcomes for the Treatment of Allergic Rhinitis. Pharmacoeconomics 10, 4–13 (1996). https://doi.org/10.2165/00019053-199610010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199610010-00002

Keywords

Search

Navigation